NCT02996968 is a NA clinical trial of Self-removal in Postoperative Urinary Retention, sponsored by TriHealth Inc..

Who is sponsoring NCT02996968?

NCT02996968 is sponsored by TriHealth Inc..

What drugs are being tested in NCT02996968?

Interventions in NCT02996968: Self-removal.

What condition does NCT02996968 study?

NCT02996968 studies Postoperative Urinary Retention.

Is NCT02996968 still recruiting?

NCT02996968 is currently completed. Last updated 12 November 2019.

Are results published for NCT02996968?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-11-12 · How we verify

NCT02996968

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Self-discontinuation of a Transurethral Catheter

Completed NA Results posted Last updated 12 November 2019

What this trial tests

NA trial testing Self-removal in Postoperative Urinary Retention in 158 participants. Completed in 16 May 2019.

Timeline

10 January 2017

Primary endpoint
16 May 2019

16 May 2019

Quick facts

Lead sponsor	TriHealth Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	158
Start date	10 January 2017
Primary completion	16 May 2019
Estimated completion	16 May 2019
Sites	1 location across United States

Drugs / interventions tested

Self-removal

Conditions studied

Postoperative Urinary Retention — all drugs for Postoperative Urinary Retention →

Sponsor

TriHealth Inc. — full company profile →

Who can join

18 and older, female only, with Postoperative Urinary Retention. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants With Postoperative Urinary Retention Primary · postoperative day 6-8

Number of Participants with postoperative urinary retention (POUR) following pelvic reconstructive surgery for pelvic organ prolapse. Pour at 1-week was defined as continued catheterization on POD 6-8

Group	Value	95% CI
Self-discontinuation Group	11
Office-discontinuation Group	11

Sponsor's own description

This study is to determine if self-discontinuation of transurethral foley catheters in patients diagnosed with postoperative urinary retention (POUR), which is defined as the continued need for catheterization, following impatient pelvic organ prolapse surgery is non-inferior to office-discontinuation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Self-Removal of a Urinary Catheter After Urogynecologic Surgery: A Randomized Controlled Trial.
Shatkin-Margolis A, Yook E, Hill AM, Crisp CC, et al · · 2019 · cited 23× · PMID 31599827 · DOI 10.1097/aog.0000000000003531
Strategies for the removal of short-term indwelling urethral catheters in adults.
Ellahi A, Stewart F, Kidd EA, Griffiths R, et al · · 2021 · cited 18× · PMID 34184246 · DOI 10.1002/14651858.cd004011.pub4

Verify or expand the search:

Other TriHealth Inc. trials

Trials by the same sponsor.

NCT07017920 — Vitamin D and Hypertensive Disorders of Pregnancy · NA · not yet recruiting
NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
NCT06958003 — Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime · NA · enrolling by invitation
NCT06957990 — Evaluation of Music Therapy for Pre-op/Intra-op During Hernia Surgery to Decrease the Need for Narcotics · NA · enrolling by invitation
NCT06414083 — Histologic Comparison of Ablative Techniques for Endometriosis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02996968 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TriHealth Inc.
Last refreshed: 12 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02996968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing